Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

M7824

- PMLiVE

Merck KGaA and Pfizer collaborate on lupus

Companies team up with academics to research treatments for autoimmune disorder

- PMLiVE

Merck KGaA loses global head of R&D

Senior reshuffle also sees departure of head of Merck Millipore

- PMLiVE

Merck KGaA appoints biosimilar head

Simon Sturge joins from Boehringer Ingelheim

- PMLiVE

Merck appoints new legal and auditing heads

Friederike Rotsch and Barbara Weiland take on senior roles

- PMLiVE

FDA clears J&J’s Imbruvica for leukaemia

Adds to cancer drug's lymphoma indication

- PMLiVE

Merck KGaA loses CFO to Lanxess

Matthias Zachert joins chemical company as CEO

- PMLiVE

Merck Serono appoints chief medical officer

Steven Hildemann joins from Merck & Co

- PMLiVE

J&J’s Imbruvica tops Arzerra in phase III trial

Shows improvement over GSK’s drug in haematological malignancies

Kleemann joins Merck from Boehringer

Appointed head of group tax

- PMLiVE

Sales down at Merck Serono on Rebif pressure

New MS drugs impact pharma company’s revenues

- PMLiVE

FDA clears J&J’s breakthrough lymphoma therapy

Imbruvica approved to treat mantle cell lymphoma

- PMLiVE

Merck Serono completes move to Germany

Closes Swiss headquarters to take up residence with parent company in Darmstadt

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links